Novel validated stability-indicating UPLC method for the estimation of naproxen and its impurities in bulk drugs and pharmaceutical dosage form

Scientia Pharmaceutica

Volumn 80, Issue 4, 2012, Pages 965-976

  Venkatarao, Papanaboina ^a,b   Nagendra Kumar, Morrisetty ^a   Ravi Kumar, Maram ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Degradation; Naproxen; Stability indicating; UPLC; Validation

Indexed keywords

NAPROXEN;

ACIDITY; ALKALINITY; ANALYTICAL PARAMETERS; ARTICLE; DEGRADATION; DRUG IMPURITY; DRUG STABILITY; FLOW RATE; HUMIDITY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MEASUREMENT ACCURACY; OXIDATION; PHOTOLYSIS; SENSITIVITY AND SPECIFICITY; SPIKE; TEMPERATURE STRESS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

EID: 84870954851     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1207-12     Document Type: Article

References (12)

1. http://www.drugs.com/naproxen.html
2. Martin M, Pablos F, Gonzalez A. Simultaneous determination of caffeine and non-steroidal anti-inflammatory drugs in pharmaceutical formulations and blood plasma by reversed-phase HPLC from linear gradient elution. Talanta 1999; 49: 453-459. http://dx.doi.org/10.1016/S0039-9140(99)00006-5
3. Perez-Ruiz T, Martinez-Lozano C, Tomas V, Carpena J. Selective determination of naproxen in the presence of nonsteroidal anti-inflammatory drugs in serum and urine samples using room temperature liquid phosphorimetry. J Pharm Biomed Anal. 1998; 17: 719-724. http://dx.doi.org/10.1016/S0731-7085(97)00228-8
4. Hirai T, Matsumoto S, Kishi I. Simultaneous analysis of several non-steroidal anti-inflammatory drugs in human urine by high-performance liquid chromatography with normal solid-phase extraction. J Chromatogr B. 1997; 692: 375-388. http://www.ncbi.nlm.nih.gov/pubmed/9188827
5. Sádecká J, Cakrt M, Hercegová A, Polonský J, Skacáni I. Determination of ibuprofen and naproxen in tablets. J Pharm Biomed Anal. 2001; 25: 881-891. http://dx.doi.org/10.1016/S0731-7085(01)00374-0
6. Ekpe A, Tong J, Rodriguez L. High-Performance Liquid Chromatographic Method Development and Validation for the Simultaneous Quantitation of Naproxen Sodium and Pseudoephedrine Hydrochloride Impurities. J Chromatogr Sci. 2001; 39: 81-86. http://www.ncbi.nlm.nih.gov/pubmed/11277256
7. Mikami E, Goto T, Ohno T, Matsumoto H, Nishida M. Simultaneous analysis of naproxen, nabumetone and its major metabolite 6-methoxy-2-naphthylacetic acid in pharmaceuticals and human urine by high-performance liquid chromatography. J Pharm Biomed Anal. 2000; 23: 917-925. http://dx.doi.org/10.1016/S0731-7085(00)00365-4
8. Monser L, Darghouth F. Simultaneous determination of naproxen and related compounds by HPLC using porous graphitic carbon column. J Pharm Biomed Anal. 2003; 32: 1087-1092. http://dx.doi.org/10.1016/S0731-7085(03)00213-9
9. Tashtoush BM, Al-Taani BM. A rapid and sensitive HPLC method for the determination of Naproxen in plasma. Acta Pharm Turc. 2003; 45: 197-201.
10. Görög S. The changing face of pharmaceutical analysis. Trends Anal Chem. 2007; 26: 12-17. http://dx.doi.org/10.1016/j.trac.2006.07.011
11. International Conference on Harmonization. ICH, Validation of Analytical Procedures: Text and Methodology (Q 2(R1)); IFPMA, Geneva, 2005.
12. International Conference on Harmonization. ICH, Stability Testing of New Drug Substances and Products (Q1AR); IFPMA, Geneva, 2000.